Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
Testosterone recovery status and speed were not significantly associated with oncologic outcomes in HRPCa patients treated with RP and ADT. These findings, the first to assess this question in a surgical cohort, provide a foundation for further research into treatment strategies, including intermittent ADT, and optimization of patient quality of life while maintaining oncologic efficacy.
Authors
- Ashley Li (ORCID: https://orcid.org/0009-0008-3394-010X)
- Kamil Malshy (ORCID: https://orcid.org/0000-0003-4130-8987)
- Trevor C. Hunt (ORCID: https://orcid.org/0000-0003-2439-7578)
- Zijing Cheng (ORCID: https://orcid.org/0000-0002-4090-7585)
- Jason Fairbourn (ORCID: https://orcid.org/0009-0001-9256-2582)
- Jathin Bandari (ORCID: https://orcid.org/0000-0001-9174-5654)
- Matthew Steidle
Institutions
- University of Rochester Medical Center (US)
Publication Details
- Journal
- The Prostate
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1002/pros.70043
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00